Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PopPK-Guided Targeted ATG Dosing in Haploidentical HSCT
NCT07862127Phase 3Recruiting
- Sponsor
- Daihong Liu
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by Daihong Liu. Started Aug 2026; status: recruiting.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT07862127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07862127.